BioCryst Pharmaceuticals Shares Outstanding 2006-2018 | BCRX

BioCryst Pharmaceuticals shares outstanding from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

BioCryst Pharmaceuticals Annual Shares Outstanding (Millions of Shares)
2018	103
2017	84
2016	74
2015	73
2014	67
2013	55
2012	49
2011	45
2010	45
2009	39
2008	38
2007	33
2006	29
2005	26

BioCryst Pharmaceuticals Quarterly Shares Outstanding (Millions of Shares)
Q4 2018	103
Q3 2018	105
Q2 2018	99
Q1 2018	99
Q4 2017	84
Q3 2017	84
Q2 2017	80
Q1 2017	75
Q4 2016	74
Q3 2016	74
Q2 2016	74
Q1 2016	74
Q4 2015	73
Q3 2015	73
Q2 2015	77
Q1 2015	72
Q4 2014	67
Q3 2014	72
Q2 2014	64
Q1 2014	60
Q4 2013	55
Q3 2013	57
Q2 2013	53
Q1 2013	51
Q4 2012	49
Q3 2012	51
Q2 2012	49
Q1 2012	47
Q4 2011	45
Q3 2011	45
Q2 2011	45
Q1 2011	45
Q4 2010	45
Q3 2010	45
Q2 2010	45
Q1 2010	44
Q4 2009	39
Q3 2009	38
Q2 2009	38
Q1 2009	38
Q4 2008	38
Q3 2008	38
Q2 2008	38
Q1 2008	38
Q4 2007	33
Q3 2007	34
Q2 2007	29
Q1 2007	29
Q4 2006	29
Q3 2006	29
Q2 2006	29
Q1 2006	29
Q4 2005	26
Q3 2005	26
Q2 2005	26
Q1 2005	24

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$0.873B	$0.021B
BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The company is advancing multiple internal programs toward potential commercialization including Fodosine in oncology, BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life threatening influenza. BioCryst has a worldwide partnership with Roche for the development and commercialization BCX-4208, and is collaborating with Mundipharma for the development and commercialization of Fodosine in markets across Europe, Asia, Australia and certain neighboring countries.

Stock Name	Country	Market Cap	PE Ratio
Zoetis (ZTS)	United States	$47.457B	31.54
Takeda Pharmaceutical (TAK)	Japan	$28.357B	10.49
Grifols (GRFS)	Spain	$12.830B	15.68
Ionis Pharmaceuticals (IONS)	United States	$10.102B	32.30
Sage Therapeutics (SAGE)	United States	$7.758B	0.00
Jazz Pharmaceuticals (JAZZ)	Ireland	$7.328B	10.49
Neurocrine Biosciences (NBIX)	United States	$7.158B	461.35
Catalent (CTLT)	United States	$6.403B	26.81
Nektar Therapeutics (NKTR)	United States	$5.516B	8.80
Tilray (TLRY)	United States	$4.740B	0.00
United Therapeutics (UTHR)	United States	$4.387B	7.46
Taro Pharmaceutical Industries (TARO)	Israel	$4.097B	13.19
FibroGen (FGEN)	United States	$4.039B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$3.793B	0.00
Portola Pharmaceuticals (PTLA)	United States	$2.252B	0.00
PTC Therapeutics (PTCT)	United States	$2.099B	0.00
USANA Health Sciences (USNA)	United States	$1.921B	16.12
Heron Therapeutics (HRTX)	United States	$1.837B	0.00
Aerie Pharmaceuticals (AERI)	United States	$1.799B	0.00
Xencor (XNCR)	United States	$1.765B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$1.738B	0.00
Arrowhead Pharmaceuticals (ARWR)	United States	$1.712B	0.00
Enanta Pharmaceuticals (ENTA)	United States	$1.668B	20.77
Madrigal Pharmaceuticals (MDGL)	United States	$1.627B	0.00
Endo (ENDP)	Ireland	$1.598B	2.46
Zogenix (ZGNX)	United States	$1.534B	0.00
Pacira Pharmaceuticals (PCRX)	United States	$1.518B	131.46
Corcept Therapeutics (CORT)	United States	$1.372B	19.93
Tricida (TCDA)	United States	$1.330B	0.00
Theravance Biopharma (TBPH)	Cayman Islands	$1.279B	0.00
Esperion Therapeutics (ESPR)	United States	$1.098B	0.00
Spectrum Pharmaceuticals (SPPI)	United States	$1.066B	0.00
TherapeuticsMD (TXMD)	United States	$1.020B	0.00
Radius Health (RDUS)	United States	$0.980B	0.00
Akebia Therapeutics (AKBA)	United States	$0.786B	0.00
CannTrust Holdings (CTST)	Canada	$0.751B	0.00
ArQule (ARQL)	United States	$0.713B	0.00
ChemoCentryx (CCXI)	United States	$0.700B	0.00
Dermira (DERM)	United States	$0.619B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$0.577B	0.00
Crinetics Pharmaceuticals (CRNX)	United States	$0.573B	0.00
Odonate Therapeutics (ODT)	United States	$0.573B	0.00
Forty Seven (FTSV)	United States	$0.559B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$0.546B	0.00
GlycoMimetics (GLYC)	United States	$0.523B	0.00
BioSpecifics Technologies Corp (BSTC)	United States	$0.460B	23.76
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.454B	0.00
Translate Bio (TBIO)	United States	$0.452B	0.00
Collegium Pharmaceutical (COLL)	United States	$0.451B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.440B	0.00
TCR2 THERAPTCS (TCRR)	United States	$0.439B	0.00
Siga Technologies (SIGA)	United States	$0.430B	0.00
OptiNose (OPTN)	United States	$0.408B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.396B	0.00
Flexion Therapeutics (FLXN)	United States	$0.388B	0.00
Aptorum Group (APM)	China	$0.388B	0.00
ImmunoGen (IMGN)	United States	$0.368B	0.00
Mast Therapeutics (SVRA)	United States	$0.334B	0.00
Harpoon Therapy (HARP)	United States	$0.317B	0.00
CASI Pharmaceuticals (CASI)	United States	$0.316B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.282B	0.00
Lannett Co Inc (LCI)	United States	$0.281B	2.61
ASSERTIO THERAPEUTICS, INC (ASRT)	United States	$0.276B	10.21
Minerva Neurosciences (NERV)	United States	$0.274B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.274B	0.00
AcelRx Pharmaceuticals (ACRX)	United States	$0.266B	0.00
Xeris Pharmaceuticals (XERS)	United States	$0.259B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.251B	0.00
Calithera Biosciences (CALA)	United States	$0.241B	0.00
Dova Pharmaceuticals (DOVA)	United States	$0.233B	0.00
Molecular Templates (MTEM)	United States	$0.231B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.228B	0.00
Concert Pharmaceuticals (CNCE)	United States	$0.222B	0.00
Ardelyx (ARDX)	United States	$0.212B	0.00
Affimed (AFMD)	Germany	$0.209B	0.00
MEI Pharma (MEIP)	United States	$0.208B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.204B	0.00
Marinus Pharmaceuticals (MRNS)	United States	$0.201B	0.00
Opexa Therapeutics (ACER)	United States	$0.200B	0.00
Galectin Therapeutics (GALT)	United States	$0.196B	0.00
La Jolla Pharmaceutical (LJPC)	United States	$0.194B	0.00
Taiwan Liposome, Unsponsored ADR (TLC)	Taiwan	$0.186B	0.00
Recro Pharma (REPH)	United States	$0.184B	0.00
Jounce Therapeutics (JNCE)	United States	$0.184B	0.00
Foamix Pharmaceuticals (FOMX)	Israel	$0.183B	0.00
Nature's Sunshine Products (NATR)	United States	$0.182B	189.00
ElectroCore (ECOR)	United States	$0.182B	0.00
Neon Therapeutics (NTGN)	United States	$0.177B	0.00
Majesco Entertainment (PTE)	United States	$0.174B	0.00
Redhill Biopharma (RDHL)	Israel	$0.172B	0.00
Aratana Therapeutics (PETX)	United States	$0.171B	0.00
IMV INC (IMV)	Canada	$0.170B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.168B	0.00
Tyme Technologies (TYME)	United States	$0.158B	0.00
Aquestive Therapeutics (AQST)	United States	$0.157B	0.00
Ocular Therapeutix (OCUL)	United States	$0.156B	0.00
Bellicum Pharmaceuticals (BLCM)	United States	$0.136B	0.00
MediWound (MDWD)	Israel	$0.132B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.119B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.114B	0.00
ProNAi Therapeutics (SRRA)	Canada	$0.109B	0.00
Cardiome Pharma (CORV)	Canada	$0.106B	0.00
Nivalis Therapeutics (ALPN)	United States	$0.105B	0.00
Natural Alternatives (NAII)	United States	$0.098B	9.62
Neos Therapeutics (NEOS)	United States	$0.097B	0.00
Zafgen (ZFGN)	United States	$0.097B	0.00
Oasmia Pharmaceutical AB (OASM)	Sweden	$0.094B	0.00
Adherex Technologies (FENC)	United States	$0.094B	0.00
DURECT (DRRX)	United States	$0.093B	0.00
Champions Oncology (CSBR)	United States	$0.092B	0.00
Adamis Pharmaceuticals (ADMP)	United States	$0.091B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.090B	0.00
Infinity Pharmaceuticals (INFI)	United States	$0.089B	0.00
Bio Blast Pharma (ENLV)	Israel	$0.083B	0.00
SCYNEXIS (SCYX)	United States	$0.083B	0.00
Otonomy (OTIC)	United States	$0.079B	0.00
Genocea Biosciences (GNCA)	United States	$0.078B	0.00
Avenue Therapeutics (ATXI)	United States	$0.075B	0.00
Entasis Therapeutics Holdings (ETTX)	United States	$0.072B	0.00
Capnia (SLNO)	United States	$0.064B	0.00
Tetraphase Pharmaceuticals (TTPH)	United States	$0.057B	0.00
CTI BioPharma (CTIC)	United States	$0.056B	0.00
Forward Pharma (FWP)	Denmark	$0.056B	0.00
Melinta Therapeutics (MLNT)	United States	$0.049B	0.00
Dipexium Pharmaceuticals (PLXP)	United States	$0.048B	0.00
Opiant Pharmaceuticals (OPNT)	United States	$0.048B	0.00
Bio-Path Holdings (BPTH)	United States	$0.048B	0.00
Lipocine (LPCN)	United States	$0.044B	0.00
KemPharm (KMPH)	United States	$0.043B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$0.043B	0.00
ContraFect (CFRX)	United States	$0.042B	0.00
Tokai Pharmaceuticals (NVUS)	United States	$0.040B	0.00
BioLineRx (BLRX)	Israel	$0.040B	0.00
Mannatechorporated (MTEX)	United States	$0.040B	0.00
Heat Biologics (HTBX)	United States	$0.038B	0.00
ProPhase Labs (PRPH)	United States	$0.035B	0.00
HANCOCK JAFFE (HJLI)	United States	$0.034B	0.00
Shineco (TYHT)	China	$0.029B	4.88
Summit Therapeutics (SMMT)	United Kingdom	$0.026B	3.47
PharmAthene (ALT)	United States	$0.025B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.024B	0.00
Jaguar Animal Health (JAGX)	United States	$0.024B	0.00
Achieve Life Sciences (ACHV)	United States	$0.024B	0.00
Biomerica (BMRA)	United States	$0.024B	0.00
Onconova Therapeutics (ONTX)	United States	$0.022B	0.00
CollPlant Holdings Sponsored ADR (CLGN)	Israel	$0.020B	0.00
NOVAN INC (NOVN)	United States	$0.020B	0.00
Cyanotech (CYAN)	United States	$0.020B	0.00
Pain Therapeutics (SAVA)	United States	$0.019B	0.00
Kitov Pharmaceuticals Holdings (KTOV)	Israel	$0.017B	0.00
Xenetic Biosciences (XBIO)	United States	$0.016B	0.00
ESSA Pharma (EPIX)	Canada	$0.015B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.014B	0.00
Eyegate Pharmaceuticals (EYEG)	United States	$0.013B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.013B	4.07
Regulus Therapeutics (RGLS)	United States	$0.012B	0.00
PRECISION THERAPEUTICS INC (AIPT)	United States	$0.012B	0.00
Achaogen (AKAO)	United States	$0.011B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.010B	0.00
RXi Pharmaceuticals (PHIO)	United States	$0.010B	0.00
DelMar Pharmaceuticals (DMPI)	Canada	$0.009B	0.00
Trillium Therapeutics (TRIL)	Canada	$0.009B	0.00
Ritter Pharmaceuticals (RTTR)	United States	$0.008B	0.00
Ohr Pharmaceuticals (OHRP)	United States	$0.006B	0.00
VAXART, INC (VXRT)	United States	$0.006B	0.00
Midatech Pharma (MTP)	United Kingdom	$0.006B	0.00
Advanced Accelerator Applications (AAAP)	France	$0.000B	0.00
Auris Medical Holding AG (EARS)	Switzerland	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00